OCUL Financials
Ocular Therapeutix Inc - Financial statements & key metrics
Stock Price
$10.57
Market Cap
$1.76B
P/E Ratio
-8.7
EPS
$-1.43
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$63.72M
Gross Profit
-
Operating Income
-
Net Income
$-193.51M
EPS (Diluted)
$-1.22
Balance Sheet Highlights
Total Assets
$457.94M
Total Liabilities
$142.59M
Shareholders Equity
-
Cash & Equivalents
$392.10M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-134.68M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-472.3%
ROE
-81.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is OCUL revenue?
OCUL's most recent quarterly revenue was $63.72M. Annual revenue can be calculated by summing the four most recent quarters.
Is OCUL profitable?
OCUL reported a loss of $193.51M in the most recent quarter.
What is OCUL market cap?
OCUL has a market capitalization of $1.76B, making it a small-cap stock.
Does OCUL have debt?
View OCUL's balance sheet for debt information.
What is OCUL cash flow?
Cash flow data is available in the full financial statements.